Synergypharma Formulations (India) Private Limited
Pharmaceutical company manufacturing and trading allopathic medicines and medical goods.
2016 | Thane, Maharashtra (India) | Inactive
Synergypharma Formulations (India) Profile
Key Indicators
- Authorised Capital ₹ 1.40 M
- Paid Up Capital ₹ 1.40 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -216.91%
- Ebitda -218.06%
- Net Worth -425.19%
- Total Assets 1155.11%
About Synergypharma Formulations (India)
Synergypharma Formulations (India) Private Limited (SFIPL) is Strike Off company established on 14 Jun 2016 with its office registered at and has been running since 8 Year, 10 Months with a paid up capital of 1.40 M. According to MCA records, 2 Directors are linked to this company as of 27 Jan 2025.
Company Details
- Location Thane, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909MH2016PTC282357
- Company No.
282357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2016
- Date of AGM
23 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Synergypharma Formulations (India) Private Limited
Explore comprehensive data for Synergypharma Formulations (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Synergypharma Formulations (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Nair  | Director | 14-Jun-2016 | Current |
| Shalini Nair | Director | 18-Feb-2020 | Current |
Financial Performance of Synergypharma Formulations (India).
Synergypharma Formulations (India) Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 216.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 425.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synergypharma Formulations (India)?
In 2018, Synergypharma Formulations (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Synergy Pharma India Private Limited
Shalini Nair is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synergypharma Formulations (India)?
Synergypharma Formulations (India) has a workforce of 88 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synergypharma Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synergypharma Formulations (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Synergypharma Formulations (India)
Recent activity within the organization
- Annual General Meeting
Synergypharma Formulations (India) Private Limited last Annual general meeting of members was held on 23 Aug 2023 as per latest MCA records.
- Balance Sheet
Synergypharma Formulations (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Shalini Nair was appointed as a Director was appointed as a Director on 18 Feb 2020 & has been associated with this company since 5 years 2 months .
- Director Appointment
Rajan Nair was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 8 years 10 months .
- Company Incorporation
Synergypharma Formulations (India) Private Limited was registered on 14 Jun 2016 with Roc Mumbai & aged 8 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Synergypharma Formulations (India) Private Limited?
Synergypharma Formulations (India) Private Limited was incorporated on 14 Jun 2016.
What is authorized share capital and paid-up capital of Synergypharma Formulations (India) Private Limited?
The authorized share capital of Synergypharma Formulations (India) Private Limited is ₹ 1.40 M and paid-up capital is ₹ 1.40 M.
Who are the current board members & directors of Synergypharma Formulations (India) Private Limited?
Currently 2 directors are associated with Synergypharma Formulations (India) Private Limited.
- Rajan Nair
- Shalini Nair
What is the registered address of Synergypharma Formulations (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Synergypharma Formulations (India) Private Limited is F/304 Glory Apartment Satelite Park Next G.C. Club, Mira Road East India, Thane, Maharashtra, 401104.
What is the corporate identification number (CIN) and company number of Synergypharma Formulations (India) Private Limited?
The corporate identification number (CIN) of Synergypharma Formulations (India) Private Limited is U51909MH2016PTC282357 and the company number is 282357 as per Ministry of Corporate Affairs (MCA).
How many employees does Synergypharma Formulations (India) Private Limited currently have?
As Per 2018 financial reports, 88 employees are currently employed by Synergypharma Formulations (India) Private Limited.
What change has been observed in the net worth of Synergypharma Formulations (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2018 indicates that The net worth of Synergypharma Formulations (India) Private Limited has experienced an downturn of -425.19%.
When was the last Balance Sheet of Synergypharma Formulations (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Synergypharma Formulations (India) Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Subramanian VaidyaDirectorPB
Premjith BalakrishnanDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India